6Z7F
C-TERMINAL BROMODOMAIN OF HUMAN BRD2 WITH N-(2-(1H-imidazol-4-yl)ethyl)-4-acetamido-3-(benzyloxy)benzamide
This is a non-PDB format compatible entry.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU FR-E+ SUPERBRIGHT |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2014-09-30 |
Detector | RIGAKU SATURN A200 |
Wavelength(s) | 1.54178 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 71.718, 52.618, 32.017 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 26.309 - 1.605 |
Rwork | 0.152 |
R-free | 0.18000 |
Structure solution method | FOURIER SYNTHESIS |
RMSD bond length | 0.003 |
RMSD bond angle | 1.159 |
Data reduction software | XDS |
Data scaling software | SCALA |
Refinement software | REFMAC (5.8.0257) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 71.720 | 1.680 |
High resolution limit [Å] | 1.600 | 1.600 |
Rmerge | 0.021 | 0.105 |
Number of reflections | 15744 | 1885 |
<I/σ(I)> | 30 | 7.8 |
Completeness [%] | 96.0 | 81.1 |
Redundancy | 3 | 1.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 6.5 | 293 | 30% PEG300, 0.1M MES |